A Multifunctional Low-Temperature Photothermal Nanomedicine for Melanoma Treatment Via the Oxidative Stress Pathway Therapy

Overview

Journal Int J Nanomedicine

Publisher Dove Medical Press

Specialty Biotechnology

Date 2024 Nov 18

PMID 39553457

Authors

Dou Zhang

Xuyi Liu

Xiong Li

Xinyi Cai

Zhenying Diao

Long Qiu

Xuelin Chen

Yuyu Liu

Jianbo Sun

Daxiang Cui

Qiaoyuan Ye

Ting Yin

Affiliations

Soon will be listed here.

Abstract

Purpose: Melanoma is a highly aggressive and dangerous malignant skin tumor and there is an urgent need to develop effective therapeutic approaches against melanoma. The main objective of this study was to construct a multifunctional nanomedicine (GNR@PEG-Qu) to investigate its therapeutic effect on melanoma from the oxidative stress pathway.

Methods: First, the nanomedicine GNR@PEG-Qu was synthesized and characterized, and its photothermal and antioxidant properties were confirmed. In addition, in vivo imaging capabilities were observed. Finally, the tumor inhibitory effects of GNR@PEG-Qu in vivo and in vitro as well as its biosafety were observed.

Results: GNR@PEG-Qu shows good photothermal and anti-oxidation properties. Following exposure to 1064 nm laser irradiation in the second near-infrared II (NIR-II) window, GNR@PEG-Qu shows anti-tumor ability through low-temperature photothermal therapy (PTT) adjuvant drug chemotherapy. GNR@PEG-Qu makes full use of the antioxidant capacity of quercetin, reduces ROS levels in melanoma, alleviates oxidative stress state, and achieves "oxidative stress avoidance" at the tumor site. Quercetin can also downregulate the expression of the heat shock protein Hsp70, which will improve the thermal sensitivity of the tumor site and enhance the efficacy of low-temperature PTT.

Conclusion: GNR@PEG-Qu nanoagent exhibits synergistic treatment and high tumor inhibition effects, which is a promising strategy developed to achieve oxidative stress avoidance and synergistic therapy of melanoma using quercetin (Qu)-coated gold nanorod (GNR@PEG).

References

Liu Y, Bhattarai P, Dai Z, Chen X . Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. Chem Soc Rev. 2018; 48(7):2053-2108. PMC: 6437026. DOI: 10.1039/c8cs00618k. View

Wang L, Shen K, Gao Z, Ren M, Wei C, Yang Y . Melanoma Derived Exosomes Amplify Radiotherapy Induced Abscopal Effect via IRF7/I-IFN Axis in Macrophages. Adv Sci (Weinh). 2024; 11(13):e2304991. PMC: 10987102. DOI: 10.1002/advs.202304991. View

Sferrazza G, Corti M, Brusotti G, Pierimarchi P, Temporini C, Serafino A . Nature-derived compounds modulating Wnt/ -catenin pathway: a preventive and therapeutic opportunity in neoplastic diseases. Acta Pharm Sin B. 2020; 10(10):1814-1834. PMC: 7606110. DOI: 10.1016/j.apsb.2019.12.019. View

Zhi D, Yang T, OHagan J, Zhang S, Donnelly R . Photothermal therapy. J Control Release. 2020; 325:52-71. DOI: 10.1016/j.jconrel.2020.06.032. View

Cao H, Cheng C, Su T, Fu X, Guo H, Li T . Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion. Mol Cancer. 2015; 14:103. PMC: 4435529. DOI: 10.1186/s12943-015-0367-4. View

Cannavo S, Tonacci A, Bertino L, Casciaro M, Borgia F, Gangemi S . The role of oxidative stress in the biology of melanoma: A systematic review. Pathol Res Pract. 2018; 215(1):21-28. DOI: 10.1016/j.prp.2018.11.020. View

Tong F, Hu H, Xu Y, Zhou Y, Xie R, Lei T . Hollow copper sulfide nanoparticles carrying ISRIB for the sensitized photothermal therapy of breast cancer and brain metastases through inhibiting stress granule formation and reprogramming tumor-associated macrophages. Acta Pharm Sin B. 2023; 13(8):3471-3488. PMC: 10465875. DOI: 10.1016/j.apsb.2022.11.003. View

Tang S, Deng X, Zhou J, Li Q, Ge X, Miao L . Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects. Biomed Pharmacother. 2019; 121:109604. DOI: 10.1016/j.biopha.2019.109604. View

Li K, Lin C, Li M, Xu K, He Y, Mao Y . Multienzyme-like Reactivity Cooperatively Impairs Glutathione Peroxidase 4 and Ferroptosis Suppressor Protein 1 Pathways in Triple-Negative Breast Cancer for Sensitized Ferroptosis Therapy. ACS Nano. 2022; 16(2):2381-2398. DOI: 10.1021/acsnano.1c08664. View

10.

Ali M, Ali H, Rankin C, El-Sayed M . Targeting heat shock protein 70 using gold nanorods enhances cancer cell apoptosis in low dose plasmonic photothermal therapy. Biomaterials. 2016; 102:1-8. DOI: 10.1016/j.biomaterials.2016.06.017. View

11.

Xu Q, Wan J, Bie N, Song X, Yang X, Yong T . A Biomimetic Gold Nanocages-Based Nanoplatform for Efficient Tumor Ablation and Reduced Inflammation. Theranostics. 2018; 8(19):5362-5378. PMC: 6276087. DOI: 10.7150/thno.27631. View

12.

Seth R, Messersmith H, Kaur V, Kirkwood J, Kudchadkar R, McQuade J . Systemic Therapy for Melanoma: ASCO Guideline. J Clin Oncol. 2020; 38(33):3947-3970. DOI: 10.1200/JCO.20.00198. View

13.

Wu Y, Yao Y, Zhang J, Gui H, Liu J, Liu J . Tumor-Targeted Injectable Double-Network Hydrogel for Prevention of Breast Cancer Recurrence and Wound Infection via Synergistic Photothermal and Brachytherapy. Adv Sci (Weinh). 2022; 9(24):e2200681. PMC: 9403641. DOI: 10.1002/advs.202200681. View

14.

Nejabat M, Samie A, Ramezani M, Alibolandi M, Abnous K, Taghdisi S . An Overview on Gold Nanorods as Versatile Nanoparticles in Cancer Therapy. J Control Release. 2023; 354:221-242. DOI: 10.1016/j.jconrel.2023.01.009. View

15.

Harris Z, Donovan M, Branco G, Limesand K, Burd R . Quercetin as an Emerging Anti-Melanoma Agent: A Four-Focus Area Therapeutic Development Strategy. Front Nutr. 2016; 3:48. PMC: 5086580. DOI: 10.3389/fnut.2016.00048. View

16.

Ma W, Sun R, Tang L, Li Z, Lin L, Mai Z . Bioactivable STING Nanoagonists to Synergize NIR-II Mild Photothermal Therapy Primed Robust and Long-Term Anticancer Immunity. Adv Mater. 2023; 35(48):e2303149. DOI: 10.1002/adma.202303149. View

17.

Ding X, Wang T, Bai S, Yang M, Peng N, Qiu T . A Dual Heat Shock Protein Down-Regulation Strategy Using PDA/Cu/ICG/R Controlled by NIR "Switch" Enhances Mild-Photothermal Therapy Effect. Adv Healthc Mater. 2023; 12(27):e2300929. DOI: 10.1002/adhm.202300929. View

18.

Franke V, van Akkooi A . The extent of surgery for stage III melanoma: how much is appropriate?. Lancet Oncol. 2019; 20(3):e167-e174. DOI: 10.1016/S1470-2045(19)30099-3. View

19.

de Melo-Diogo D, Pais-Silva C, Dias D, Moreira A, Correia I . Strategies to Improve Cancer Photothermal Therapy Mediated by Nanomaterials. Adv Healthc Mater. 2017; 6(10). DOI: 10.1002/adhm.201700073. View

20.

Chu M, Zheng C, Chen C, Song G, Hu X, Wang Z . Targeting cancer stem cells by nutraceuticals for cancer therapy. Semin Cancer Biol. 2021; 85:234-245. DOI: 10.1016/j.semcancer.2021.07.008. View